Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids

Guardado en:

Detalles Bibliográficos
Publicado en:	Nature Communications vol. 6 (Oct 2015), p. 8715-8727
Autor principal:	Freedman, Benjamin S
Otros Autores:	Brooks, Craig R, Lam, Albert Q, Fu, Hongxia, Morizane, Ryuji, Agrawal, Vishesh, Saad, Abdelaziz F, Li, Michelle K, Hughes, Michael R, Werff, Ryan Vander, Peters, Derek T, Lu, Junjie, Baccei, Anna, Siedlecki, Andrew M, Valerius, M Todd, Musunuru, Kiran, Mcnagny, Kelly M, Steinman, Theodore I, Zhou, Jing, Lerou, Paul H, Bonventre, Joseph V
Publicado:	Nature Publishing Group
Materias:	Harvard University Brigham & Womens Hospital University of Washington Harvard Medical School United States > US Massachusetts Physiology Embryos CRISPR Regenerative medicine Kidney diseases Genetic engineering Hospitals Stem cells Medical schools Cell culture Nephrology Kidneys Social
Acceso en línea:	Citation/Abstract Full Text Full Text - PDF
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!